stars 1 stars 2 stars 3

Syntiron LLC, is dedicated to developing innovative vaccines for humans. Our patented microbial antigen discovery and purification technology targets proteins that acquire iron, a critical nutrient that is required for survival of the bacteria. These proteins are expressed on the cell surface and are similar among different strains, making them ideal vaccine antigens. Our proprietary platform enables rapid identification of these proteins, which can then be directly extracted from the host cell or produced recombinantly for preclinical vaccine development.

Syntiron Questions

The Syntiron annual revenue was $4 million in 2026.

Lisa Herron-Olson is the Managing Director of Syntiron.

8 people are employed at Syntiron.

Syntiron is based in Saint Paul, Minnesota.

The NAICS codes for Syntiron are [325414, 3254, 32541, 325, 32].

The SIC codes for Syntiron are [283, 28].

Top Syntiron Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users